Skip to main content
Gregory Priebe, MD, Pediatric Infectious Disease, Boston, MA

Gregory P Priebe MD


Director of Research, Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital; Associate Member, Broad Institute of MIT and Harvard; Associate Professor, Harvard Medical School

Join to view full profile
  • 300 Longwood AveDiv. Critical Care Med. Children's Hosp. Boston Bader 6Boston, MA 02115

  • Phone+1 617-355-7327

Dr. Priebe is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 1997 - 2001
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1993 - 1997
  • Harvard Medical School
    Harvard Medical SchoolClass of 1993

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1996 - 2027
  • Pediatric Critical Care Medicine
    American Board of Pediatrics Pediatric Critical Care Medicine
  • Pediatric Infectious Diseases
    American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity (IMPACT-CETR)BOSTON CHILDREN'S HOSPITAL2025–2030
  • Vaccines for Pseudomonas aeruginosaDepartment of Defense2019–2023
  • Th17-inducing vaccines for Pseudomonas aeruginosa in cystic fibrosisCystic Fibrosis Foundation2017–2019
  • Targeting Burkholderia FixL as a novel antimicrobial strategy in CFCystic Fibrosis Foundation2013–2015
  • Mechanisms Of Adaptive Immunity To P. Aeruginosa In The LungNational Heart, Lung, And Blood Institute2009–2012

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: